Migraine does not cause brain damage

November 25, 2007

Migraine does not cause cognitive impairment, according to a new Danish twin study. This important finding reassures millions of migraine sufferers and confirms our clinical observation. Another recent study in mice suggested that inducing brain changes similar to what occurs during a migraine attack in humans can cause brain damage. This report was widely circulated in the media and has caused unnecessary anxiety in many migraine sufferers. Clearly, whatever those mice experienced was not a migraine attack and, more importantly, brains of mice are very different from human brains.

The Danish study looked at 139 pairs of twins where one of the twins had migraines and the other one did not. Comparing their cognitive abilities revealed no difference for those who had migraine with or without aura, even after taking into account age, age of onset, duration of migraine history and number of attacks. Presence of aura is thought to indicate a more serious condition with a slight increase in the risk of stroke. However, on one cognitive test, men with migraine with aura did better than their twin without migraines.

Written by
Alexander Mauskop, MD
Continue reading
May 21, 2026
Research
Your Brain Has Many Pathways, And TMS Can Now Use Them
A groundbreaking University of Iowa study shows that personalized fMRI-guided TMS can now reach and modulate the deep hippocampus — the brain’s command center for memory, emotion, and migraine — without surgery or heavy medications. By mapping each patient’s unique neural pathways, TMS delivers precise stimulation to surface “control points” that influence deep brain structures. Generic approaches barely work, but individualized targeting produces clear, measurable changes. At our headache clinic, we combine TMS and fMRI to offer this advanced, personalized treatment for migraines, depression, PTSD, anxiety, and more.
Read article
May 10, 2026
Research
Elismetrep: A Promising New Experimental Migraine Treatment
Elismetrep is a promising experimental migraine medication that targets the TRPM8 pathway rather than serotonin or CGRP. Early clinical trials suggest it may offer a new option for patients who do not respond well to current treatments.
Read article
May 6, 2026
Alternative Therapies
New Research on Brain Excitability and TMS Treatment for Migraine
New research shows how the brain dynamically regulates excitability in real time—and why this matters for transcranial magnetic stimulation (TMS) as a treatment for migraine.
Read article
Insights from Dr. Alexander Mauskop on headaches and migraines
Subscribe to the Blog.
Subscribe
Subscribe